Pathophysiology of ion channels in amyotrophic lateral sclerosis.

Authors:
Stringer RN; Weiss N.

Journal:
Mol Brain

Publication Year: 2023

DOI:
10.1186/s13041-023-01070-6

PMCID:
PMC10722804

PMID:
38102715

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mol Brain

Abbreviation: Mol Brain

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Crucial role of TFAP2B in the nervous system for regulating NREM sleep.
Nakai A; Kashiwagi M; Fujiyama T and 6 more (2024) - Transparency Score: 3/6
Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from…
Bhalla M; Lee CJ. (2024) - Transparency Score: 4/6
Mutant α-synuclein causes death of human cortical neurons via ERK1/2 and JNK activation.
Suzuki H; Egawa N; Imamura K and 8 more (2024) - Transparency Score: 3/6
Neurexin-1-dependent circuit activity is required for the maintenance of photoreceptor subtype iden…
Lim-Kian-Siang G; Izawa-Ishiguro AR; Rao Y. (2024) - Transparency Score: 3/6
Spermidine treatment: induction of autophagy but also apoptosis?
Watchon M; Wright AL; Ahel HI and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors have no competing interests to declare. Competing interests The authors have no competing interests to declare."

Evidence found in paper:

"Funding N.W. is supported by a grant from the Czech Science Foundation (GACR #22-23242S), the Ministry of Education, Science, Research and Sport of the Slovak Republic (VEGA #2/0073/22), and the National Institute for Research of Metabolic and Cardiovascular Diseases (Program EXCELES # LX22NPO5104), funded by the European Union—Next Generation EU."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025